Latest Tax Refunds News

Spacetalk Ltd has secured an $877k R&D tax refund for FY2025, more than doubling last year’s amount, underscoring its strategic pivot to software and a 20% growth in recurring revenue.

Elixir Energy’s upcoming Lorelle-3 appraisal well in Queensland’s Taroom Trough has qualified for a substantial federal R&D tax incentive, covering nearly half of its drilling and testing costs. This financial boost underpins the company’s ambitious plans to validate a major gas play in 2026.

Elixir Energy has received a $3.861 million R&D tax refund, providing crucial funding for its upcoming Taroom Trough appraisal drilling and production testing programs.

Tombador Iron Limited is set to transform into Atomic Eagle Limited through its acquisition of GoviEx Uranium Inc, creating a new ASX-listed uranium explorer focused on Africa’s Muntanga Project. A capital raise of up to A$10 million will underpin this strategic pivot.

Pilot Energy has made significant strides in its offshore Perth Basin exploration with environmental approval for a major seismic survey and secured substantial financing to support its ongoing projects and transition to clean energy.

AXP Energy has drilled its inaugural vertical well in Oklahoma following a significant lease acquisition and raised A$2.7 million to fund exploration, while production in Colorado declined due to operational challenges.

Omega Oil and Gas has bolstered its balance sheet with a $46 million equity placement and confirmed the strong commercial potential of its Canyon Project, setting the stage for a major appraisal campaign in 2026.

Vitasora Health Limited reported robust patient program growth and secured new US partnerships, driving revenue above A$1 million for the quarter. A recent A$11 million capital raise positions the company for continued expansion and cash-flow breakeven by late 2026.

Imugene Limited reports an 81% overall response rate in its azer-cel CAR T-cell therapy trial for difficult lymphomas, alongside a $25 million capital raise that extends its cash runway to mid-2027.

BCAL Diagnostics has secured key partnerships and a $10 million convertible note facility to expand its cancer detection tests across Australia and New Zealand, marking steady commercial progress in Q3 2025.

Control Bionics reports a strong start to FY26 with nearly 10% revenue growth, expanded US reimbursement coverage, and advancing commercialization of its NeuroNode and NeuroStrip technologies.

Elixir Energy reports promising gas pay results at Diona-1 and secures a premium drilling rig for the upcoming Lorelle-3 appraisal well, positioning itself for a pivotal phase in the Taroom Trough.